Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05123482
Title First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications

ovarian serous carcinoma

endometrial cancer

triple-receptor negative breast cancer

cholangiocarcinoma

ovarian cancer

Advanced Solid Tumor

breast cancer

Therapies

AZD8205

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.